Involvement of the digestive system in covid-19. A review
Copyright © 2020 Elsevier España, S.L.U. All rights reserved..
The SARS-CoV-2 pandemic is leading to high mortality and a global health crisis. The primary involvement is respiratory; however, the virus can also affect other organs, such as the gastrointestinal tract and liver. The most common symptoms are anorexia and diarrhea. In about half of the cases, viral RNA could be detected in the stool, which is another line of transmission and diagnosis. covid19 has a worse prognosis in patients with comorbidities, although there is not enough evidence in case of previous digestive diseases. Digestive endoscopies may give rise to aerosols, which make them techniques with a high risk of infection. Experts and scientific organizations worldwide have developed guidelines for preventive measures. The available evidence on gastrointestinal and hepatic involvement, the impact on patients with previous digestive diseases and operating guidelines for Endoscopy Units during the pandemic are reviewed.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:43 |
---|---|
Enthalten in: |
Gastroenterologia y hepatologia - 43(2020), 8 vom: 11. Okt., Seite 464-471 |
Sprache: |
Englisch |
---|
Weiterer Titel: |
Afectación del aparato digestivo en la covid-19. Una revisión sobre el tema |
---|
Beteiligte Personen: |
Sanz Segura, Patricia [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 19.10.2020 Date Revised 11.11.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.gastrohep.2020.06.004 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM314325743 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM314325743 | ||
003 | DE-627 | ||
005 | 20231225152503.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.gastrohep.2020.06.004 |2 doi | |
028 | 5 | 2 | |a pubmed24n1047.xml |
035 | |a (DE-627)NLM314325743 | ||
035 | |a (NLM)32859408 | ||
035 | |a (PII)S0210-5705(20)30220-X | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Sanz Segura, Patricia |e verfasserin |4 aut | |
245 | 1 | 0 | |a Involvement of the digestive system in covid-19. A review |
246 | 3 | 3 | |a Afectación del aparato digestivo en la covid-19. Una revisión sobre el tema |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 19.10.2020 | ||
500 | |a Date Revised 11.11.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2020 Elsevier España, S.L.U. All rights reserved. | ||
520 | |a The SARS-CoV-2 pandemic is leading to high mortality and a global health crisis. The primary involvement is respiratory; however, the virus can also affect other organs, such as the gastrointestinal tract and liver. The most common symptoms are anorexia and diarrhea. In about half of the cases, viral RNA could be detected in the stool, which is another line of transmission and diagnosis. covid19 has a worse prognosis in patients with comorbidities, although there is not enough evidence in case of previous digestive diseases. Digestive endoscopies may give rise to aerosols, which make them techniques with a high risk of infection. Experts and scientific organizations worldwide have developed guidelines for preventive measures. The available evidence on gastrointestinal and hepatic involvement, the impact on patients with previous digestive diseases and operating guidelines for Endoscopy Units during the pandemic are reviewed | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Systematic Review | |
650 | 4 | |a Aparato digestivo | |
650 | 4 | |a Digestive system | |
650 | 4 | |a Endoscopia digestiva | |
650 | 4 | |a Gastrointestinal endoscopy | |
650 | 4 | |a Hígado | |
650 | 4 | |a Liver | |
650 | 4 | |a Pandemia | |
650 | 4 | |a Pandemics | |
650 | 4 | |a Review | |
650 | 4 | |a Revisión | |
650 | 4 | |a SARS-CoV-2 | |
650 | 4 | |a covid-19 | |
650 | 7 | |a Aerosols |2 NLM | |
650 | 7 | |a Antiviral Agents |2 NLM | |
650 | 7 | |a Immunosuppressive Agents |2 NLM | |
650 | 7 | |a Receptors, Virus |2 NLM | |
650 | 7 | |a Peptidyl-Dipeptidase A |2 NLM | |
650 | 7 | |a EC 3.4.15.1 |2 NLM | |
650 | 7 | |a ACE2 protein, human |2 NLM | |
650 | 7 | |a EC 3.4.17.23 |2 NLM | |
650 | 7 | |a Angiotensin-Converting Enzyme 2 |2 NLM | |
650 | 7 | |a EC 3.4.17.23 |2 NLM | |
700 | 1 | |a Arguedas Lázaro, Yolanda |e verfasserin |4 aut | |
700 | 1 | |a Mostacero Tapia, Sonia |e verfasserin |4 aut | |
700 | 1 | |a Cabrera Chaves, Tomás |e verfasserin |4 aut | |
700 | 1 | |a Sebastián Domingo, Juan José |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Gastroenterologia y hepatologia |d 1993 |g 43(2020), 8 vom: 11. Okt., Seite 464-471 |w (DE-627)NLM075187280 |x 0210-5705 |7 nnns |
773 | 1 | 8 | |g volume:43 |g year:2020 |g number:8 |g day:11 |g month:10 |g pages:464-471 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.gastrohep.2020.06.004 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 43 |j 2020 |e 8 |b 11 |c 10 |h 464-471 |